glp-1 impact on bariatric surgery Volumes | Ragui Sadek MD FACS FASMBS posted on the topic GLP-1 vs Bariatric Surgery: Which

The preference for metformin as the initial agent is based on its durable efficacy in lowering A1C, absence of risk for hypoglycemia or weight gain, relatively mild side-effect profile, longterm safety track record, and affordability

[74] analyzed the FAERS data from 2005 to October 2023, revealing a notable incidence of suicidal ideation and depression linked to semaglutide and liraglutide, with no recorded cases of suicidal behaviors or completed suicides

Buckley ST, Bkdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Rnne J, et al

Mitochondrial dysfunction: A potential target for alzheimers disease intervention and treatment

If my blood work moves in a direction I dont want it to go in, then Ill talk with Dr

[10] With this ingredient list you may see mild stimulant effects and small bumps in calorie burn, but not the proven results of real GLP-1s